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Multifocal Langerhans Cell Histiocytosis  
in an Adult
Natalie Nielsen, MD, Ali Akalin, MD, Hartley M. Sirkis, MD, and Mathew J. Most, MD  
Eosinophilic granuloma (EG) is the most common benign form of Langerhans cell histiocytosis (LCH). Initially described by Lichtenstein in 1953, LCH en-
compasses a triad of proliferative granulomatous disorders pri-
marily affecting children: EG, Hand-Schüller-Chris-
tian disease, and Letterer-Siwe disease.1 Lichtenstein 
first termed the disease histiocytosis X, after recognizing 
that the 3 syndromes had the same histology.1 The 
term was updated after the clonal proliferation of 
Langerhans cells in the pathogenesis of the disease 
was discovered.
As LCH is generally considered a pediatric disease, 
there is little in the literature regarding adult-onset 
LCH. The incidence of LCH in adults is reported as 
1 to 2 cases per million, significantly lower than that in 
children.2,3 Two studies have reported the mean age at 
diagnosis in adults as the fourth decade of life, and have 
suggested a male predominance.4,5 The vast majority of 
adult LCH cases described are simple EG, with very few 
cases of multisystem disseminated disease reported.5  
 Adult patients with LCH typically present with 
solitary lesions in bone. Approximately 10% of cases 
have extraosseous involvement, with the lung being 
the most common site.6 Lesions tend to be unifo-
cal, with fewer than 10 reports describing multifocal 
EG.1,7-13 The axial skeleton is most frequently involved, 
with the majority of lesions occurring in the skull, ribs, verte-
brae, or mandible.14 While less common, the femur, humerus, 
and clavicle are most often involved when the appendicular 
skeleton is affected.5  
Abstract
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Figure 1. (A) Anteroposterior and (B) lateral radiographs of the patient’s right 
distal femur. (A) Note the metaphyseal, cortically based, destructive lesion 
of the medial distal femur (arrow), which is unusual for eosinophilic granu-
loma (EG) and should raise concern for possible aggressive metastatic 
carcinoma, despite the patient’s history of EG.
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Eosinophilic granuloma (EG) is the most common and 
benign form of the spectrum of disorders referred to as 
Langerhans cell histiocytosis (LCH). Langerhans cell his-
tiocytosis is primarily regarded as a pediatric disease, with 
few adult cases of multifocal EG of bone reported. 
We report a case of multifocal EG in a 48-year-old 
woman, who presented with right knee pain. Radiographs 
showed a small lytic lesion in the medial femoral condyle. 
Diagnosis was confirmed by ultrasound-guided biopsy. 
She had had a previous EG lesion excised from her skull. 
Whole-body bone scan demonstrated a new skull lesion 
in the right diploic space, which was confirmed by mag-
netic resonance imaging. The patient underwent curet-
tage, bone grafting, and prophylactic internal fixation of 
the right distal femur lesion. The skull lesion was treated 
with repeat craniectomy. 
Two years later, she developed a new lesion in the right 
distal femoral metaphysis, which was treated with intra-
lesional corticosteroid injections. Now, more than 1 year 
later, the patient is pain-free with no evidence of new or 
recurrent disease. Because multifocal EG is a rare diag-
nosis in adults, appropriate clinical suspicion, in combina-
tion with radiographic findings and histologic examination, 
is essential for correct diagnosis and treatment.  
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In a literature review, a few case reports describe adult-onset 
EG of the skull. Only 5 case reports since the 1970s describe 
adult patients with EG of the femur. We present a rare case 
of multifocal EG in a 48-year-old woman with lesions of the 
femur and skull, as well as a review of the literature. The patient 
provided written informed consent for print and electronic 
publication of this case report. 
Case Report
A 48-year-old woman presented with progressive right knee 
pain that was exacerbated by weight-bearing. She denied 
trauma, fevers, fatigue, or weight change. Her history was 
significant for an EG of the skull, excised at an outside institu-
tion 2 years prior to presentation. The patient also admitted to 
recent onset of right-sided skull pain, near the region of her 
previous surgery. 
Physical examination demonstrated tenderness to palpa-
tion and fullness over the right medial distal femur and a 
normal neurovascular examination of the right lower extrem-
ity. Radiographs of the knee showed a cortically based, lytic, 
destructive lesion involving the medial femoral condyle, with 
soft-tissue extension (Figures 1A, 1B). Magnetic resonance 
imaging (MRI) of the right knee showed the lesion, with ex-
traosseous soft-tissue extension (Figures 2A, 2B). The mass 
was isointense to muscle on T1-weighted images and hyper-
intense on T2-weighted images. Technetium bone scanning 
showed increased uptake in the right femur and the right skull 
(Figures 3A, 3B). MRI of the brain confirmed a new lesion in 
the right diploic space, distinct from the previous EG lesion site 
(Figures 4A-4D). An ultrasound-guided biopsy of the femur 
was performed and was consistent with EG. 
After reevaluation and clearance by her neurosurgeon, the 
patient underwent curettage and allografting of the femoral 
lesion, with prophylactic internal fixation using a titanium 
distal femoral locking plate (Figure 5). Intraoperative frozen 
section was consistent with EG, which was confirmed with 
additional immunohistochemical workup (Figures 6A-6D).   
The patient recovered uneventfully and follow-up radio-
graphs showed restoration of the bony cortex of the medial 
femoral condyle (Figure 7). The second skull lesion, which 
was also consistent with EG, was excised by her neurosurgeon. 
The patient remained asymptomatic until 2 years later, 
when she began experiencing mild pain in her right distal 
thigh and knee. Radiographs showed a new lytic focus in the 
right distal metadiaphysis (Figure 8) which was not present on 
her last radiograph 6 months prior. A computed tomography 
Figure 2. (A) T1-weighted and (B) T2-weighted coronal magnetic 
resonance imaging of the patient’s right knee. Note the cortically 
based lesion medially (arrows), with extraosseous soft-tissue 
extension, which is hypointense on the T1-weighted images and 
hyperintense on the T2-weighted images. 
Figure 3. Technetium bone scan images of the patient’s bilateral 
knees (A, anteroposterior view) and skull (B, lateral view). (A) Note 
the intense uptake at the medial aspect of the right distal femur. 
(B) In the skull, note the intense uptake associated with the new 
lesion (dotted arrow) as well as the lack of uptake at the site of the 
previous craniectomy (solid arrow).
Figure 4. (A-D) Four consecutive axial gadolinium-enhanced T1-weighted magnetic resonance images with fat suppression, showing a 
small round avidly enhancing lesion in the right parietal bone (arrow), geographically separate from the site of the previous lesion, which 
was treated with a craniectomy (circle). 
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(CT) scan showed a lytic lesion involving the right distal femur 
medullary canal with cortical thinning and destruction, most 
pronounced posteriorly (Figures 9A, 9B). There was also an 
extraosseous soft-tissue component to the lesion. Bone scan 
showed increased uptake in the area of the new lesion. There 
was no increased uptake elsewhere, including the medial distal 
femur at the site of the old lesion, to suggest other lesions, and 
no increased uptake in the skull. 
Given that the location of the lesion was distinct from the 
prior site of curettage and bone grafting, it was thought to be 
consistent with a new EG lesion. The patient underwent CT-
guided biopsy, with simultaneous intralesional corticosteroid 
injection to treat the lesion when on-site pathology confirmed 
the etiology. Further surgical 
management was deemed 
unnecessary because inter-
nal fixation was present and 
spanned the new lesion. 
Final analysis of the fine- 
needle aspirate of the new 
lesion was positive for nu-
merous eosinophils and his-
tiocytes, consistent with EG. 
At 6-week follow-up af-
ter the intralesional steroid 
injection, the patient’s pain 
continued to abate, and 
she was ambulating with 
crutches. Repeat CT scan 
of the right distal femur 
showed improvement of 
the extraosseous soft-tissue 
component, while the lu-
cency in the femur itself re-
mained unchanged. The decision was made to proceed with 
a second intralesional corticosteroid injection under CT guid-
ance. The patient’s symptoms continued to improve, and repeat 
imaging 1 year after her steroid injections showed substantial 
bony healing with reconstitution of her cortical bone (Figures 
10A-10E). 
The patient had had 4 distinct tumors consistent with EG 
and was referred to a medical oncologist for further workup. 
The patient began treatment with zoledronic acid to prevent 
Figure 5. Immediate postopera-
tive anteroposterior radiograph 
of the patient’s distal femur, 
after treating her eosinophilic 
granuloma lesion with curet-
tage, bone grafting, and pro-
phylactic internal fixation.  
Figure 6. (A) Sheets of Langerhans cells admixed with other 
inflammatory cells, including numerous eosinophils and rare 
multinucleated giant cells (hematoxylin-eosin [H&E] stain, original 
magnification ×100). (B) High-power view shows the characteristic 
oval or kidney bean–shaped nuclei of Langerhans cells sur-
rounded by pale eosinophilic cytoplasm and admixed numerous 
scattered eosinophils (H&E stain, original magnification ×400).  
(C) Tumor cells are positive for S100 protein, displaying both 
nuclear and cytoplasmic staining (S100 immunostain, original 
magnification ×400). (D) In addition, tumor cells are positive for 
CD1a antigen, displaying membranous staining (CD1a immunos-
tain, original magnification ×400).
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Figure 7. Anteroposterior radio-
graph of the patient’s right distal 
femur at 18-month follow-up. Note 
the restoration of cortical integrity 
medially, at the site of the previous 
lesion (arrow).
Figure 8. Anteroposterior 
radiograph of the patient’s 
right distal femur 2 years 
after the index procedure, 
showing a new lucent med-
ullary lesion (more typical 
of eosinophilic granuloma), 
geographically distinct from 
the previous lesion (arrow).
Figure 9. (A) Axial and (B) coronal computed tomography 
(CT) images showing the new lucent lesion in the distal femur, 
which was biopsied under CT guidance and confirmed to be an 
eosino philic granuloma lesion.
A B
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development of further lesions. At most recent follow-up, the 
patient was 18 months out from her second intralesional cor-
ticosteroid injection and was doing very well. She reported 
being pain-free and was walking 3 to 4 miles per week without 
gait aids. There was no evidence of new disease. The medial 
distal femur lesion was completely healed, and the distal me-
taphyseal lesion was nearly healed, with very little residual 
evidence of lesions.  
Discussion
Adult-onset multifocal EG is a rare entity. Most affected pa-
tients develop lesions in the axial skeleton, with the skull, 
mandible, and vertebrae most commonly involved.14 Only 5 
cases of femoral EG have been reported, one of which was 
multifocal.11,14-17 
Of these patients, 3 were between the ages of 33 and 53 
years and had insidious onset of hip pain that failed conserva-
tive management.14,15,17 Further imaging and biopsy revealed 
unifocal EG in the proximal femur in each case. Each patient 
received a different form of treatment, including curettage and 
radiation, radiofrequency ablation, and/or physical therapy. At 
the time of publication, all patients had reported improvement 
in their clinical symptoms.14,15,17 The fourth patient was a man 
with human immunodeficiency virus (HIV) with 3 months of 
progressive thigh pain. Further evaluation found an isolated EG 
of the femoral diaphysis that progressed to pathologic fracture. 
He was treated with curettage and intramedullary nailing, and 
had improved symptoms and radiographic signs of healing at 
30-month follow-up.16   
An interesting case by Kerzl and colleagues11 reported a 
63-year-old woman with a 24-year history of multiple sym-
metric lesions of the femora, leading to multiple pathologic 
fractures. Like our patient, her initial lesion was in the skull. 
Initial pathology specimens led to the diagnosis of EG. How-
ever, as the patient aged, she developed symptoms of diabetes 
insipidus and xanthelasma, which led to reevaluation of histol-
ogy from 3 bony lesions. The patient was determined to have 
multifocal EG of the skull and femur, with simultaneous oc-
currence of Erdheim-Chester disease, which also causes bone 
lesions in addition to diabetes insipidus and xanthelasma.11       
Though LCH was initially described more than 50 years ago, 
many aspects of LCH remain an enigma, especially in adults. 
The etiology of the disease is poorly understood. Controversy 
exists regarding whether LCH is primarily an immunoregula-
tory, neoplastic, or reactive disorder. The vast majority of adult 
cases described in the literature are EG, with very few cases of 
multisystem disseminated disease reported.5       
The spectrum of disorders constituting LCH is heterog-
enous. Eosinophilic granuloma is the most common form, 
reportedly accounting for 60% to 70% of all cases, usually 
presenting as solitary bone lesions.6 Eosinophilic granuloma 
refers to the localized form of LCH, in which the disease is 
limited to bone or lung.18 This is the least aggressive form of 
the disease, with the most favorable prognosis. Hand- Schüller-
Christian disease is a chronic, recurring form of LCH, with 
disseminated disease, affecting both bone and extraskeletal 
sites. Hand-Schüller-Christian disease is known for the clas-
sic triad of diabetes insipidus, exophthalmos, and destructive 
bone lesions. Patients may also present with otitis media or 
neurologic complaints from pathologic vertebral fractures. 
Letterer-Siwe disease refers to the acute, disseminated, fulmi-
nant form of LCH. This is the least common form of LCH and 
is predominately described in young children. Patients present 
with hepatosplenomegaly, lymphadenopathy, skin rash, fever, 
anemia, and thrombocytopenia.19 It is rapidly progressive, 
leading to multiorgan dysfunction and death within 1 to 2 
years.18 
The classification of LCH follows the Histiocyte Society 
guidelines developed from multicenter randomized trials in 
children.3 Classification is based on affected organs and is di-
vided into 2 categories: single-system disease or multisystem disease. 
Single-system disease may be single site (bone, skin, or solitary 
lymph node) or multisite (multifocal bone disease or multiple 
lymph nodes). Multisystem disease is further classified into 
low-risk or risk groups. The low-risk group involves dissemi-
nated disease without involvement of risk organs (lungs, liver, 
spleen, and hematopoietic system). Involvement of 1 or more 
risk organs places the patient in the risk group, associated with 
the least favorable prognosis.3  
In adults, the most common presenting symptoms are local 
pain from bony involvement, weight loss, and fever. Bony le-
sions most often occur in the skull, especially in the jaw. Long 
Figure 10. (A) Anteroposterior radiograph and (B-E) axial computed tomography images approximately 1 year after a series of 2 intral-
esional corticosteroid injections, showing extensive healing of the second femoral lesion.
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bones are less frequently involved, with lesions occurring in 
the long bones in approximately 17% of patients.3 The rib has 
also been reported as a common site of involvement in adults.5 
Similar to children, diabetes insipidus remains a classic mani-
festation of LCH because of pituitary gland involvement. Other 
common symptoms of LCH in adults are cough, dyspnea, and 
chest pain from pulmonary involvement. Up to 20% to 30% of 
adult LCH patients have isolated pulmonary lesions, although 
pulmonary LCH may also occur as part of multisystem disease 
(risk group).3,4,20 
Eosinophilic granuloma bone lesions have a variety of ra-
diographic appearances but most commonly appear as lytic 
lesions. They often mimic aggressive lesions with permeative 
bone destruction, periostitis, ill-defined borders, and cortical 
erosion. Most lesions arise in the medullary space but can 
present as a destructive, cortically based lesion, as it did in 
our patient’s first femoral lesion. The differential diagnosis for 
a lytic medullary bone lesion includes benign entities, such 
as nonossifying fibromas, bone cysts, or osteomyelitis, but 
also includes malignant tumors, such as metastases, Ewing 
sarcoma, and lymphoma. A destructive, cortically based lesion 
in an adult should raise a very high suspicion for metastatic 
carcinoma until proven otherwise. Other diagnostic consid-
erations for a cortically based lesion include chondromyxoid 
fibroma and surface bone lesions, such as surface chondroma 
and osteoma, or osteosarcoma (parosteal and periosteal). In 
the skull, lesions commonly erode the outer table more than 
the inner table (the typical “beveled-edge” appearance). Skull 
lesions also may have a small, central, dense focus within the 
lytic lesion (“button sequestrum”). 
Bone scanning is often not as sensitive in detecting EG 
lesions compared with other bone tumors, although in our 
patient the bone scan was positive. In patients with a nega-
tive bone scan but a high index of suspicion, a radiographic 
skeletal survey should be obtained to rule out other lesions. 
MRI typically shows T2-hyperintense, T1-hypointense lesions 
with surrounding bone marrow edema and variable contrast 
enhancement, which is relatively nonspecific. The high sen-
sitivity of MRI allows accurate delineation of the extent of the 
lesions and evaluates for the presence of an extraosseous soft-
tissue component. Biopsy is generally necessary to establish 
a definitive histologic diagnosis. In our patient, despite her 
history of biopsy-proven EG, the aggressive appearance of a 
destructive, cortically based lesion made obtaining a biopsy 
critical to establish a definitive diagnosis in this case.
The histopathologic examination of the tissue from our 
patient was typical of that seen in patients with EG. It revealed 
tissue fragments with diffuse sheets of histiocytes displaying 
nuclear grooves, admixed numerous eosinophils with eosino-
philic microabscesses, and scattered lymphocytes (Figures 6A, 
6B). There were areas of necrosis, raising the possibility of os-
teomyelitis. However, the presence of classic histomorphologic 
features of LCH in the majority of the tissue fragments, along 
with CD1a- and S100-positivity in the histiocytes, confirmed 
the diagnosis of LCH (Figures 6C, 6D). Although not highly 
specific, a positive CD1a immunostain with the described his-
tomorphologic findings in the proper clinical setting is often 
considered sufficient for LCH diagnosis. S100 is an important 
adjunct immunostain in the evaluation of histiocytic disorders. 
A positive S100 immunostain helps identify histiocytes, which 
are also CD1a-positive, because the latter immunostain can also 
be positive in some lymphomas and thymomas.21 
After diagnosis of LCH has been confirmed, staging includes 
radiographs of any suspicious bone lesions, chest radiograph, 
bone scan, abdominal ultrasound, routine laboratory studies, 
and chest CT if pulmonary LCH is suspected. 
The optimal treatment strategy for adult patients has not 
been clearly defined, and current strategies for LCH vary de-
pending on organ involvement and extent of disease. Thera-
peutic options include observation, local treatment with 
steroids, local excision with curettage with or without bone 
grafting, chemotherapy, immunomodulation, irradiation, and 
stem cell transplantation in advanced disease. In general, pa-
tients who benefit from systemic therapy, such as chemother-
apy or immunomodulation, include those with multisystem 
disease, refractory or recurrent lesions, and multifocal skeletal 
involvement.22   
Patients with more limited disease, such as EG of bone, 
may undergo observation or local intralesional treatment. Eo-
sinophilic granuloma of bone may resolve spontaneously and 
commonly does so when it is located in the pediatric spine. 
However, the therapeutic approach in adults with EG is contro-
versial, given that spontaneous resolution is less likely to occur 
in the skeletally mature. Plasschaert and colleagues23 reported 
a recurrence rate of 26% in skeletally mature patients with 
EG of bone treated with biopsy followed by curettage with or 
without grafting. In the skeletally immature group, there were 
no clinical or radiographic signs of recurrence in the 2-year 
follow-up period.23 Thus, treatment in the adult population 
must be considered separate from the skeletally immature and 
in the appropriate clinical context. Depending on the location 
of the lesion, patients may become symptomatic or be at risk 
for pathologic fracture. In such circumstances, curettage with 
or without bone grafting and prophylactic internal fixation 
may be indicated. Other treatments, such as intralesional in-
filtration with corticosteroids, have been reported, but the role 
of such treatment in adults is undetermined.24,25 Radiation is 
typically not recommended in single-system disease unless a 
Bone scanning is often not as sensitive in 
detecting EG lesions compared with other 
bone tumors.…In patients with a negative 
bone scan but a high index of suspicion, 
a radiographic skeletal survey should be 
obtained to rule out other lesions.
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vital organ is threatened.26 Overall, patients with single-system 
disease have an excellent prognosis, and treatment should be 
determined on an individual basis.3 
Eosinophilic granuloma represents less than 1% of all bone 
tumors, and adult presentation is very rare. The differential 
diagnosis of lytic bone lesions is broad and includes metastatic 
carcinoma, lymphoma/myeloma, osteomyelitis, osteoblas-
toma, aneurysmal bone cyst, and Ewing sarcoma. While EG is 
more common and easily diagnosed in children, it should be 
considered in the differential diagnosis in adults, so that the ap-
propriate diagnostic workup and treatment can be performed. 
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